Montara Therapeutics
San Francisco, US · Founded 2022 · Delaware corporation · 25 employees on LinkedIn · 4 known investors
Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's. It was founded by scientists whose prior company, Mitokinin, was acquired by AbbVie in 2023.
Founders & leadership
Montara Therapeutics was founded in 2022 by Kevan Shokat and Thomas Südhof.
KS
Kevan ShokatCo-Scientific Founder & Chairman of the SAB
TS
Thomas SüdhofCo-Scientific Founder & SAB Member
SS
Seth StrattonNamed on SEC filing
DL
Dirk LangdorfNamed on SEC filing
NH
Nicholas HertzNamed on SEC filing
Investors · 4
Reported raises · per SEC filings
Form D private placements$28M disclosed across 2 rounds · 2024–2025
▶$20MraisedMar 2025 · 9 investors · BiotechnologyRule 506(b)
▶$20MraisedMar 2025 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Max LebovitzExecutive Officer
- Seth StrattonDirector
- Troy WilsonDirector
- Zachary HillExecutive Officer
- Rishi RakhitExecutive Officer
- Randall ChinExecutive Officer
- Dirk LangdorfDirector
- Nicholas HertzExecutive Officer, Director, Promoter
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$8MraisedJan 2024 · 5 investors · BiotechnologyRule 506(b)
▶$8MraisedJan 2024 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Seth StrattonDirector
- Dirk LangdorfDirector
- Nicholas HertzExecutive Officer, Director
- Offering amount
- $17M
- Amount sold
- $8M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Montara Therapeutics went on to found or lead other companies.
Competitors · 2
by search overlap
Neumora Therapeutics20 shared keywordsNeumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
Bioworld19 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Montara Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Montara Therapeutics do?
- Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's. It was founded by scientists whose prior company, Mitokinin, was acquired by AbbVie in 2023.
- Who founded Montara Therapeutics?
- Montara Therapeutics was founded by Kevan Shokat, Thomas Südhof in 2022.
- Who are Montara Therapeutics's investors?
- Montara Therapeutics's investors include Two Bear Capital, Dementia Discovery Fund, Dolby Family Ventures, KdT Ventures.
- How much funding has Montara Therapeutics raised?
- Montara Therapeutics has disclosed $28M raised across 2 rounds.
- Where is Montara Therapeutics headquartered?
- Montara Therapeutics is headquartered in San Francisco, US.